Medical Coverage Policy Electromagnetic Navigational Bronchoscopy
Defines medical necessity and non-coverage positions for electromagnetic navigation bronchoscopy (ENB) for Medicare Advantage and commercial products, including diagnostic use for peripheral pulmonary lesions and fiducial marker placement; excludes ENB for mediastinal lymph node diagnosis and other unaddressed uses.
No material clinical or coverage changes in this update.
Coverage Summary
Overview: This policy (effective 2020-01-01, last reviewed 2024-07-17) defines medical necessity and non-coverage positions for Electromagnetic Navigation Bronchoscopy (ENB). The coverage stance is mixed: ENB is supported as medically necessary in specified situations (diagnosis of suspicious peripheral pulmonary lesions and placement of fiducial markers when standard bronchoscopy/EBUS are inadequate) and is considered not covered/not medically necessary for other uses, including diagnosis of mediastinal lymph nodes. Glossary: ENB — Electromagnetic navigation bronchoscopy (see definition block).